Insider sale
TENAYA THERAPEUTICS, INC.
$2.60M
3.92M shares
What this filing means
COLUMN GROUP III-A, LP plans to sell 3.92M shares of TENAYA THERAPEUTICS, INC. valued at approximately $2.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/20/2026ACC: 0001178937-26-000008
10% Owner
Since Jul 2021
3.92M
Shares to sell
$2.60M
Approx. market value
1.59M
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Series A financing
Cash
12/20/2018
1.37MSeries A financing
Cash
7/31/2017
225.89KTotal acquired1.59M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/20/2018 | Series A financing Cash | 1.37M | — |
7/31/2017 | Series A financing Cash | 225.89K | — |
| Total | 1.59M | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.15M
Market value
$1.46M
2/11/2026
—Completed
Units to sell
182.29K
Market value
$148.8K
2/10/2026
Planned — Approximate Date
NASDAQ GSPlanned
Units to sell
1.59M
Market value
$985.4K
2/20/2026
Total
Units
3.92M
Value
$2.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2026 | 2.15M | $1.46M | — | Completed |
2/10/2026 | 182.29K | $148.8K | — | Completed |
| Planned — Approximate Date | ||||
2/20/2026 | 1.59M | $985.4K | NASDAQ GS | Planned |
| Total | 3.92M | $2.60M | ||